Get the Stockscreener App
9.115
0.71%
-0.065
Fennec Pharmaceuticals Inc stock is traded at $9.115, with a volume of 10,082.
It is down -0.71% in the last 24 hours and up +11.57% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$9.18
Open:
$9.2
24h Volume:
10,082
Relative Volume:
0.15
Market Cap:
$251.38M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-14.94
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
+2.76%
1M Performance:
+11.57%
6M Performance:
+35.04%
1Y Performance:
+69.74%
1-Day Range:
$9.00
$9.29
1-Week Range:
$8.73
$9.29
52-Week Range:
$3.96
$9.42
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
9.038 | 255.49M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.30 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.14 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.59 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
747.50 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Fennec Pharmaceuticals Rings the Closing Bell - Nasdaq
Ranking Fennec Pharmaceuticals Inc. among high performing stocks via toolsAnalyst Downgrade & Community Consensus Stock Picks - Newser
What Fibonacci levels say about Fennec Pharmaceuticals Inc. reboundTrade Analysis Report & Momentum Based Trading Ideas - Newser
Using R and stats models for Fennec Pharmaceuticals Inc. forecasting2025 Technical Overview & Stock Timing and Entry Methods - Newser
Measuring Fennec Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Forecasting Fennec Pharmaceuticals Inc. price range with options dataWeekly Risk Report & Verified Entry Point Signals - Newser
Fennec Pharmaceuticals Inc. stock trendline breakdown2025 Market Sentiment & AI Optimized Trade Strategies - Newser
Chart overlay techniques for tracking Fennec Pharmaceuticals Inc.Market Growth Summary & Community Consensus Picks - Newser
How Fennec Pharmaceuticals Inc. stock performs during market volatility2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
FenneC Pharmaceuticals Director Raykov Rosty Sells 10,000 Shares for $8.92 Each. - AInvest
Is Fennec Pharmaceuticals Inc.’s growth already priced inTrade Ideas & Free Community Supported Trade Ideas - khodrobank.com
Is Fennec Pharmaceuticals Inc. a candidate for recovery play2025 Valuation Update & Accurate Entry and Exit Point Alerts - Newser
Is Fennec Pharmaceuticals Inc. stock bottoming outMarket Growth Report & Risk Managed Trade Strategies - Newser
Combining machine learning predictions for Fennec Pharmaceuticals Inc.Market Performance Report & Verified Stock Trade Ideas - Newser
What’s the fair value of Fennec Pharmaceuticals Inc. stockEntry Point & Smart Money Movement Alerts - khodrobank.com
Is this a good reentry point in Fennec Pharmaceuticals Inc.Trend Reversal & Entry and Exit Point Strategies - Newser
Using data models to predict Fennec Pharmaceuticals Inc. stock movementTrade Exit Summary & Daily Growth Stock Tips - Newser
Custom strategy builders for tracking Fennec Pharmaceuticals Inc.2025 Market Sentiment & Growth Focused Investment Plans - Newser
Pattern recognition hints at Fennec Pharmaceuticals Inc. upsideJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Tools to monitor Fennec Pharmaceuticals Inc. recovery probability2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Using Python tools to backtest Fennec Pharmaceuticals Inc. strategiesWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Exit strategy if you’re trapped in Fennec Pharmaceuticals Inc.2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Has Fennec Pharmaceuticals Inc. found a price floorQuarterly Market Review & Expert Approved Momentum Trade Ideas - Newser
Fennec Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
Is Fennec Pharmaceuticals Inc. forming a bottoming baseEarnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Published on: 2025-09-03 04:52:27 - Newser
Analyzing Fennec Pharmaceuticals Inc. with risk reward ratio chartsQuarterly Investment Review & Real-Time Market Sentiment Alerts - Newser
How much upside does Fennec Pharmaceuticals Inc. have2025 Growth vs Value & Step-by-Step Swing Trade Plans - khodrobank.com
Aug Setups: What’s the fair value of Fennec Pharmaceuticals Inc. stockJuly 2025 Review & Real-Time Buy Signal Notifications - khodrobank.com
Is Fennec Pharmaceuticals Inc. stock trending bullishWeekly Stock Report & Weekly High Momentum Picks - khodrobank.com
Analyzing net buyer seller activity in Fennec Pharmaceuticals Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Tools to assess Fennec Pharmaceuticals Inc.’s risk profileJuly 2025 Spike Watch & Reliable Price Action Trade Plans - Newser
What is Fennec Pharmaceuticals Inc.’s valuation compared to sector2025 Investor Takeaways & Precise Trade Entry Recommendations - khodrobank.com
Is Fennec Pharmaceuticals Inc. subject to activist investor interestMarket Risk Analysis & Real-Time Price Movement Reports - khodrobank.com
Short Covering: What is Fennec Pharmaceuticals Inc.’s valuation compared to sectorLayoff News & Technical Buy Zone Confirmation - khodrobank.com
What momentum shifts mean for Fennec Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - Newser
Is Fennec Pharmaceuticals Inc. stock ready for a breakoutLong Setup & Fast Gain Swing Trade Alerts - Newser
Fennec Pharmaceuticals Inc. Consolidation Zone May Signal Accumulation getLinesFromResByArray error: size == 0 - 강소기업뉴스
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fennec Pharmaceuticals Inc Stock (FENC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Raykov Rosty | Director |
Sep 04 '25 |
Sale |
8.92 |
10,000 |
89,200 |
51,086 |
| Raykov Rosty | Director |
Aug 05 '25 |
Sale |
8.09 |
10,000 |
80,900 |
55,878 |
0.23%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):